Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report)'s share price was up 10.5% during mid-day trading on Thursday . The stock traded as high as C$1.87 and last traded at C$1.69. Approximately 138,161 shares changed hands during mid-day trading, an increase of 54% from the average daily volume of 89,599 shares. The stock had previously closed at C$1.53.
Cardiol Therapeutics Stock Down 4.9%
The firm's 50-day simple moving average is C$1.84 and its 200 day simple moving average is C$1.68. The company has a debt-to-equity ratio of 1.59, a quick ratio of 6.84 and a current ratio of 2.49. The stock has a market capitalization of C$144.38 million, a P/E ratio of -3.42 and a beta of 0.70.
About Cardiol Therapeutics
(
Get Free Report)
Cardiol Therapeutics Inc NASDAQ: CRDL TSX: CRDL is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.
See Also
Before you consider Cardiol Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.
While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access